NAS:VECT (Switzerland)  
VectivBio Holding AG logo

VectivBio Holding AG

$ 5.05 -0.46 (-8.35%) 10:39 AM EST
P/E:
At Loss
P/B:
1.45
Market Cap:
$ 207.08M
Enterprise V:
$ 144.11M
Volume:
372.00
Avg Vol (2M):
10.33K
Volume:
372.00
Market Cap $:
207.08M
PE Ratio:
At Loss
Avg Vol (2-Month):
10.33K
Enterprise Value $:
144.11M
PB Ratio:
1.45
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

VectivBio Holding AG
NAICS : 325412 SIC : 2834
Aeschenvorstadt 36, Basel, CHE, 4051
Description
VectivBio Holding AG is a clinical stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe rare conditions for which there is a significant unmet medical need. The product candidate is apraglutide, which is a next generation, long-acting synthetic peptide analog of glucagon-like peptide-2, or GLP-2, which is developed as a differentiated therapeutic for a range of rare GI diseases, with an initial focus on short bowel syndrome.
Name Current Vs Industry Vs History
Cash-To-Debt 351.75
Equity-to-Asset 0.85
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 44.02
9-Day RSI 45.53
14-Day RSI 46.64
6-1 Month Momentum % 8.23
12-1 Month Momentum % -17.39

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 6.41
Quick Ratio 6.41
Cash Ratio 5.98

Dividend & Buy Back

Name Current Vs Industry Vs History

Financials (Next Earnings Date:2022-08-31 Est.)

VECT's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:VECT

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -3.23
Beta 0
Volatility % 67.62
14-Day RSI 46.64
14-Day ATR ($) 0.471502
20-Day SMA ($) 5.584425
12-1 Month Momentum % -17.39
52-Week Range ($) 2.7426 - 8.9
Shares Outstanding (Mil) 44.74

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

VectivBio Holding AG Filings

Document Form Filing Date
No Filing Data

Headlines

See More